Rapid protection against hepatitis A and B using an accelerated vaccination schedule: comparison of combined vaccine, Twinrix, with separate vaccines.
Nothdurft, Hans D; Dietrich, Manfred; Zuckerman, Jane N; Knobloch, Jürgen; Kern, Peter; Sänger, Roland.
; 17 Suppl 1: 15-8, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12785873
Comparative immunogenicity of two vaccination schedules of a combined hepatitis A and B vaccine in healthy volunteers.
A Randomized Controlled Trial to Evaluate a Potential Hepatitis B Booster Vaccination Strategy Using Combined Hepatitis A and B Vaccine.
Combined hepatitis A and B vaccine: providing a bright future for preventing hepatitis.
Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
Hepatitis A immunisation in persons not previously exposed to hepatitis A.
Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine.
Immunity to hepatitis A and B persists for at least 15 years after immunisation of adolescents with a combined hepatitis A and B vaccine.
[The immunological effectiveness and reactogenicity of the vaccine "HEP-A+B-in-VAC" against hepatitis A and B].
Immunogenicity, effectiveness and safety of combined hepatitis A and B vaccine: a systematic literature review.
The effects of booster vaccination on combined hepatitis A and hepatitis B vaccine in both anti-HBs and anti-HAV negative children 5-15 years after hepatitis B vaccine primary immunization.